Remimazolam Induction in a Patient with Super-Super Obesity and Obstructive Sleep Apnea: A Case Report
<i>Background</i>: With the rising prevalence of obesity, anesthesiologists are expected to increasingly encounter patients with obesity, which poses challenges for anesthetic management. The use of remimazolam, an intravenous anesthetic agent approved in 2020, may be beneficial in these...
Main Authors: | Sou Hyun Lee, Hyeji Han |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/59/7/1247 |
Similar Items
-
An anesthetic experience with remimazolam for MELAS patients
by: Atsuhiro Kitaura, et al.
Published: (2022-08-01) -
Remimazolam as an Adjunct to General Anesthesia in Children: Adverse Events and Outcomes in a Large Cohort of 418 Cases
by: Yoshitaka Kimoto, et al.
Published: (2023-06-01) -
The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis
by: Ching-Chung Ko, et al.
Published: (2023-02-01) -
A case of precipitate in intravenous line when general anesthesia implemented with remimazolam
by: Yingge Liu, et al.
Published: (2022-12-01) -
Effects of Remimazolam Anesthesia with Two Induction Doses on Hemodynamics and Recovery Profile in Older Patients: Comparison with Propofol Anesthesia
by: Tae Kwang Kim, et al.
Published: (2023-08-01)